• Tue, June 7, 2022
  • Mon, June 6, 2022

Tiago Fauth Maintained (BMRN) at Buy with Increased Target to $106 on, Jun 6th, 2022

Tiago Fauth of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $105 to $106 on, Jun 6th, 2022.

Tiago has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tiago


  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $113 on, Monday, April 25th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $125 on, Thursday, February 24th, 2022

WOPRAI
Market Predictions Driven by AI

Like: 👍